Association Between Plasma D Dimer in Adult CAP and Severity of Inflammatory Response and Survival
ConditionD-dimer
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorAin Shams University
About this trial
This observational study aims to investigate the association between elevated plasma D-dimer levels and the inflammatory response, as well as its impact on survival in adult patients with community-acquired pneumonia.
the study participants will be subjected to sampling for D-dimer and calculation of CURB-65 score. this aims to find the relation between them
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
age ≥18 years
diagnosis of CAP based on clinical symptoms, laboratory findings, and radiological evidence.
Disqualifiers
Patients with a history of coagulation disorders, cancer, or other chronic diseases, or refusal to participate.
patients who have any clinical or radiological signs suggesting COVID-19 pneumonia.
Trial population
the participant is those patients with CAP WHO will meet the inclusion criteria previously mentioned
Trial design
Design model
Case-only
Time perspective
Cross-sectional
Treatments tested in this trial
Blood Product
Other interventionblood sample for D-dimer
Treatment groups
50 Participants
are divided into 1 treatment groupGroup A: only one group which will include patients with CAP to take a blood sample for D-dimer1 intervention
Trial outcomes
Primary outcomes
1
find the correlation between plasma D-dimer level and the severity of CAP
measuring D-dimer level (\< 500 µg/L consider negative) on admission and correlating this with CAP severity.
Time frame
in 6 monthsSponsors and contacts
Click on the lead sponsor to view all of their trials.
Source ClinicalTrials.gov